Talking to Your Doctor
You have made the wise decision to talk to your doctor about your vision and possible risk for glaucoma. This section is designed to help you make the most of your visit.
How do I prepare for my eye examination?
To help you better prepare for your eye examination, we have developed an appointment questionnaire. Print it out and take it to your appointment. It will help you start a productive talk with your doctor.
Where can I find an eye doctor in my area?
The following are some resources that may help you locate an eye doctor in your area. Be sure to ask if the doctor performs complete eye exams including glaucoma checks.
Ophthalmologists:
Optometrists:
These Web sites are neither owned nor controlled by Pfizer. Pfizer is not responsible for the content or services on these sites.
Will my insurance pay for eye exams?
Insurance coverage for eye examinations varies from one plan to another. Call your insurance plan provider to determine if they cover the cost of an eye examination.
Medicare currently covers a yearly dilated eye examination for people at high risk for glaucoma. For more information, visit the Medicare Web site.
Next: Tools
How XALATAN Works
What to Ask the Doctor
Indication
XALATAN is for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.
Important Safety Information
Like all medicines, XALATAN can have side effects. These side effects are usually mild and tolerable and may include blurred vision, burning and stinging, eye redness, the feeling of something in the eye, eye itching, increased pigmentation (darkening) of eye color, or irritation of the clear front surface of the eye.
XALATAN may slowly cause darkening of the eye color due to increased brown color, darkening of the eyelid and eyelashes, and increased growth and thickness of eyelashes. Color changes can increase as long as XALATAN is administered and eye color changes are likely to be permanent.
The recommended dosage is one drop (1.5 µg) in the affected eye(s) once daily in the evening. If one dose is missed, treatment should continue with the next dose as normal.
There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.
Pfizer is a licensee of the TRUSTe Privacy Program.© 2009 Pfizer Inc. All rights reserved.
XLU00691 D